POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Todd Cooper, DO
Emory University/Children's Healthcare of Atlanta
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- the Children'S Hospital of Denver
Denver, Colorado, United States
- Children'S Healthcare of Atlanta/emory University
Atlanta, Georgia, United States
- Johns Hopkins Medical Center
Baltimore, Maryland, United States
- the Children'S Mercy Hospital and Clinics
Kansas City, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Penn State Hershey Children'S Hospital
Hershey, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 28 Jun 2013
- Completion
- 28 Jun 2016
- Last update posted
- 7 Sept 2018
- Registered enrollment
- 20
- Registry id
- NCT01319864
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.